Resonance Specialties Limited (BOM:524218)

Market Cap	1.93B +64.1%
Revenue (ttm)	1.02B +24.2%
Net Income	145.10M +90.7%
EPS	12.58 +91.0%
Shares Out	11.54M
PE Ratio	13.30
Forward PE	n/a
Dividend	1.00 (0.62%)
Ex-Dividend Date	Jul 28, 2026

Volume	9,712
Open	174.95
Previous Close	171.25
Day's Range	165.10 - 174.95
52-Week Range	77.00 - 188.50
Beta	0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in agrochemicals, pharmaceuticals, latexes, food, and allied industries, as well as to manufacture vitamins, medicines, food flavoring, dyes, adhesives, pesticides, herbicides, etc.; and picolines, including beta and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chro...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 74
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524218

Financial Performance

In fiscal year 2026, Resonance Specialties's revenue was 902.48 million, an increase of 15.99% compared to the previous year's 778.07 million. Earnings were 103.96 million, an increase of 58.32%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 11, 2026

Data Sources Report a data error